Experienced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Dr. Pavel Klein

Neurology

6410 Rockledge Dr, Suite 610,

Bethesda, MD

Accepting New Patients

Offers Telehealth

Experienced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

6410 Rockledge Dr, Suite 610,

Bethesda, MD

OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Pavel Klein is a Neurologist in Bethesda, Maryland. Dr. Klein is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, and Post-Traumatic Epilepsy. Dr. Klein is currently accepting new patients.

His clinical research consists of co-authoring 97 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Neurology

Licenses

Psychiatry & Neurology in MD

Languages Spoken

English

Czech

German

Russian

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem

Blue Cross Blue Shield

Blue Shield of California

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

BMC HealthNet

HMO
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP

Cambia Health Solutions

EPO
INSURANCE PLAN
MEDICARE MAPD
MEDICARE PDP
OTHER COMMERCIAL
OTHER MEDICARE
PPO

CareFirst

Cigna

Health Care Services Corporation

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

Highmark

Horizon Healthcare

Humana

HMO
INDEMNITY
POS
PPO

Independent Health

Johns Hopkins Healthcare

HMO
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE-MEDICAID PLAN

Kaiser Permanente

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
OTHER MEDICARE
POS
PPO

Managed Medicaid

OTHER MANAGED MEDICAID

Medicaid

OTHER MEDICAID
STATE MEDICAID

Medical Card System

INSURANCE PLAN
MEDICARE MAPD
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE PART D
PPO

Medicare

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE PART D

Premera Blue Cross

INSURANCE PLAN
MEDICARE MAPD
OTHER COMMERCIAL
PPO

Sentara Healthcare

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE ASSISTANCE PROGRAM
MEDICARE MAPD
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

UnitedHealthcare

UPMC

Walgreens

MEDICARE DISCOUNT CARD
MEDICARE PDP
OTHER MEDICARE

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 20 Less Insurance Carriers -

Locations

6410 Rockledge Dr, Suite 610, Bethesda, MD 20817

Call: 301-530-9744

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)

Enrollment Status: Terminated

Publish Date: October 08, 2025

Intervention Type: Drug

Study Drug: Soticlestat

Study Phase: Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)